Pharmacology of bile acids and their derivatives: Absorption promoters and therapeutic agents

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 31, Issue 3, 2006, Pages 237-251

  Mikov, M ^a,b   Fawcett, J P ^a,c   Kuhajda, K ^d   Kevresan, S ^d  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c JILIN UNIVERSITY   (China)

^d UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Bile acid derivatives; Bile acids; Pharmacology; Promoters; Therapeutic agents

Indexed keywords

3ALPHA,7ALPHA DIHYDROXY 12 KETO 5ALPHA CHOLIC ACID; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID DERIVATIVE; MORPHINE; PENETRATION ENHANCING AGENT; PENTOBARBITAL; QUININE; SODIUM; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ACUTE PANCREATITIS; ANALGESIC ACTIVITY; BILIARY CIRRHOSIS; BLOOD BRAIN BARRIER; CANCER; CANCER PREVENTION; CHOLESTEROL STONE; CYSTIC FIBROSIS; DIABETES MELLITUS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG POTENTIATION; DRUG TRANSPORT; DRUG UPTAKE; GALLSTONE; GASTROINTESTINAL DISEASE; HUMAN; INTESTINE ABSORPTION; NONHUMAN; REVIEW; SCLEROSING CHOLANGITIS; SEXUALLY TRANSMITTED DISEASE; SKIN ABSORPTION; SLEEP TIME;

EID: 33751518532     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190714     Document Type: Review

References (109)

1. nd edition, Elsevier, The Netherlands.
2. Hsieh D. (ed.) (1994): Drug Permeation Enhancement Theory and Applications. Marcel Dekker Inc, New York.
3. Sayani A.P., Chien Y.W. (1996): Critical Reviews In Therapeutic Drug Carrier Systems 13, 85.
4. Trauner M., Boyer J. (2003): Physiol. Rev. 83, 633.
5. O'Reilly J., Corrigan O., O'Driscoll C. (1994): Int. J. Pharm. 109, 147.
6. Mesiha M., Ponnapula S., Plakogiannis F. (2002): Int. J. Pharm. 249, 1.
7. Michael S., Thole M., Dillmann R., Fahr A., Drewe J., Fricker G. (2000): Eur. J. Pharm. Sci. 10, 133.
8. Mrestani Y., Bretschneider B., Harti A., Neubert R. (2003): J. Pharm. Pharmacol. 55, 1601.
9. Newton J.M., Rowley G., Tomblom J.V. (1971): J. Pharm. Pharmacol 23, 156S.
10. Borras-Blasco J., Diez-Sales O., Lopez A., Herraez-Dominguez M. (2004): Int. J. Pharm., 269.
11. Hye J.A., Kyoung M.K., Kim C.-K. (1998): Drug Devel. Indust. Pharm. 24, 697.
12. Martin-Algarra R.V., Pascual-Costa R.M., Merino M., Casabo V.G. (1994): Pharm. Res. 11, 1042.
13. Senel S., Hoogstraate F., Spies J.C., Verhoef H.E., Junginger H.E., Bodde H.E. (1993): Eur. J. Morphol. 31, 35.
14. Nakane S., Kakumoto M., Yukimatsu K., Chien Y.W. (1996): Pharmac. Devel. Technol. 1, 251.
15. Deneer V., Drese G., Roemele P., Verhoef J., Lie-A-Huen L., Kingma J., Brouwers J., Junginger H. (2002): Int. J. Pharm. 241, 127.
16. Gandhi R., Robinson J.R. (1985): Int. J. Pharmacol. 85, 129.
17. Lee V.H.L., Yamamoto A., Kompella U.B. (1991): Crit. Rev. Ther. Drug Carrier Systems 8, 91.
18. Hofer C., Hartung R., Göbel R., Deering P., Lehmer A., Breul J. (2000): World J. Surg. 24, 1187.
19. Cevc G., Blume G., Schatzlein A., Gebauer D., Paul A. (1996): Advanced Drug Delivery Systems 18, 349.
20. Paul A., Cevc G. (1995): Vaccine Res. 4, 145.
21. Guo J., Ping Q., Huang L.J. (1999): China Pharm. Unv. 30, 184-186.
22. Cevc G., Blume G. (1992): Biochem. Biophys. Acta 1104, 226.
23. Nokhodchi A., Shokri J., Dashbolaghi A., Hassan-Zadeh D., Ghafourian T., Barzegar-Jalali M. (2003): Int. J. Pharm. 250, 359.
24. Shokri J., Nokhodchi A., Dashbolaghi A., Hassan-Zadeh D., Ghafourian T., Barzegar-Jalali M. (2001): Int. J. Pharm. 228, 99.
25. Yamamoto A., Luo A., Dodda-Kashi S., Lee V. (1989): J. Pharmacol. Exp. Ther. 249, 249.
26. Longenecker J., Moses A., Flier J., Silver R., Carey M., Dubovi (1987): J. Pharm. Sci. 76, 351.
27. Samiy N., D'Amico D.J. (1996): Intt. Ophthalmol. Clin. 36, 147.
28. nd Edition, Little, Brown, Boston.
29. Souri E.N., Green W.R. (1974): Am. J. Ophthalmol. 78, 77.
30. Doft B.H., Weiskopf J., Nilsson-Ehle I., Wingard L.B. (1985): Ophthalmology 92, 1601.
31. Tremblay C., Barza M., Szoka F., Lahav M., Baum J. (1985): Invest. Ophthalmol. Vis. Sci. 26, 711.
32. Cannon J.P., Fiscella R., Pattharachayakul S., Garey K.W., De Alba F., Piscitelli S., Edward D.P., Danziger L.H. (2003): Invest. Ophthalmol. Vis. Sci. 44, 2112.
33. Shao Z., Mitra A.K. (1992): Pharm. Res. 9, 1184.
34. Gordon G.S., Moses A.C., Silver R.D., Flier J.S., Carey M.C. (1985): Proc. Natl. Acad. Sci. 82, 7419.
35. Junginger H.E. (1992): Drug Targeting and Delivery: Concepts in dosage form design. Ellis Horwood Limited, England.
36. Hersey S.J, Jackson R.T. (1987): J. Pharm. Sci. 76, 877.
37. Ilium L., Fischer A.N., Jabbal-Gill I., Davis S.S. (2001): Int. J. Pharm. 222, 109.
38. Bjork E., Bjurstron S., Edman P. (1991): Int. J. Pharm. 75, 73.
39. Hirai S., Ikenaga T., Matsuzawa T. (1978): Diabetes 27, 296.
40. Moses A.C., Gordon G.S., Carey M.C., Flier J.S. (1983): Diabetes 32, 1041.
41. Alberts B., Bray D., Lewis J., Raff M., Roberts K., Watson J. (eds) (1983): Molecular Biology of the Cell. Garland, New York.
42. Donovan M.D., Flynn G.L., Amidon G.L. (1990): Pharm Res., 7, 808.
43. Aungst B.J., Rogers N.J., Shefter E. (1988): J. Pharmacol. Exp. Ther. 244, 23.
44. Agu R.U., Ugwoke M.I., Armand M., Ringet R., Verbeke N. (2001): Respir. Res. 2, 198.
45. Heinemann L., Kloppoth W., Rave K., Hompesch B., Linkeschowa R., Heise T. (2000): Diabetes Care, 23, 1343.
46. Fukuda Y., Tsuji T., Fujita T., Yamamoto A., Muranishi S. (1995): Biol. Pharm. Bull. 18, 891.
47. th Edition, McGraw-Hill, Boston.
48. Yamamoto A., Okumura S., Fukuda Y., Fukui M., Takahashi K., Muranishi S. (1997): J. Pharm. Sci. 86, 1144.
49. Morita T., Yamamoto A., Takakura Y., Hashida M., Sezaki H. (1994): Pharm. Res. 11, 909.
50. Kaneko T., Sato T., Katsuya H., Miyauchi Y. (1990): Crit. Care Med. 18, 77, 1990.
51. Watanaube A., Fujuwara M., S. Tominaga, Nagashima H. (1987): Hiroshima J. Med. Sci. 36, 257.
52. Spiegelman M.K., Zappulla R.A., Malis L.I., Holland J.F., Goldsmith S.J., Goldberg J.D. (1983): Neurosurgery 12, 606.
53. Mikov M., Kevresan S., Kuhajda K., Jakovljevic V., Vasovic V. (2004): Polish J. Pharmacol. 56, 367.
54. Lloyd G., Sutton P.M., Atkinson T. (1988): Lancet 25, 1418.
55. Fenner F., White D.O. (1970): Med. Virol. Academic Press.
56. Herold B.C., Kirkpatrick R., Marcellino D., Travelstead A., Pilipenko K., Krasa H., Bremer J., Dong L.J., Cooper M.D. (1999): Antimicrob. Agents Chemother. 43, 745.
57. Kowdley K. V. (2000): Am. J. Med. 108, 481.
58. Poupon R.E., Balkau B., Eschwege E., Poupon R. (1991): N. Engl. J. Med. 324, 1548.
59. Poupon R.E., Lindor K.D., Cauch-Dudek K., Dickson E.R., Poupon R., Heathcote E.J. (1997): Gastroenterology 113, 884.
60. Paumgartner G., Beuers U. (2002): Hepatology 36, 525.
61. Beuers U., Spengler U., Kruis W., Aydemir U., Wiebecke B., Heldwein W., Weinzier L.M., Pape G.R., Sauerbruch T., Paumgartner G. (1992): Hepatology 16, 707.
62. Ransohoff D.F., Gracie W.A. (1993): Annals Intern. Med. 119, 607.
63. Danzinger R.G., Hofmann A.F., Schoemfield L.J., Thistle J.L. (1972): N. Engl. J. Med. 286, 1.
64. Makino I., Hashimoto H., Shinozaki K., Nakagawa S. (1975): Jpn. J. Gastroenterol. 72, 690.
65. Salen G., Nicolau G., Shefer S. (1973): Clin. Res. 21, 523.
66. Coyne M.J., Bonorris G.G., Goldstein L.J. (1976): J. Lab. Clin. Med. 87, 281.
67. Angelin B., Ewerth S., Einarsson K. (1983): J. Lipid Res. 24, 461, 1983.
68. W.G. Hardison, S.M. Grundy, Gastroenterology, 87, 130.
69. Maudgal D.P., Northfield T.C. (1991): Drugs 41, 185.
70. Bell G.D., Dowling R.H., Whitney B., Sutor D.J. (1975): Gut 16, 359.
71. Maudgal D.P., Kupfer R.M., Northfield T.C. (1983): Gut 24, 7.
72. Gonzalez-Koch A., Nervi F. (1998): World J. Surg. 22, 1145.
73. Maton P.N., Iser J.H., Reuben A., Saxton H.M., Murphy G.M., Dowling R.H. (1982): Medicine 61, 86.
74. Bouchier I.A.D. (1988): Gut 29, 137.
75. Salvioli G., Salati R., Lugli R., Zanni C. (1983): Gut 29, 609.
76. Ros E., Navarro S., Bru C., Gilabert R., Bianchi L., Bruguera M. (1993): Lancet 342, 404.
77. Mok H.Y.I., Bell G.D., Dowling R.H. (1974): Lancet 2, 253.
78. Schoenfield L.J., Lachin J.M. (1981): Annals Intern. Med. 95, 257.
79. Lanzini A., Facchinetti D., Pigozzi M.G. (1991): Scand. J. Gastroenterol. 26, 551.
80. Maton P.N., Murphy G.M., Dowling R.H. (1977): Lancet 2, 1297.
81. Chadwick V.S., Gaginella T.S., Carlson G.L. (1979): J. Lab. Clin. Med. 94, 661.
82. Bateson M.C., Bouchier I.A.D., Trash D.B. (1981): Br. Med. J. 283, 645.
83. Villanova N., Bazzoli F., Taroni F., Frabboni R., Mazzella G., Festi D., Barbara L., Roda E. (1989): Gastroenterology 97, 726.
84. Duan R.D., Erlanson-Albertson C. (1986): Scand. J. Gastroenterol. 21, 1211.
85. Duan R.D., Erlanson-Albertson C. (1985): Scand. J. Gastroenterol. 20, 1239.
86. th Edition, Williams and Wilkins, New York.
87. Takeyama Y., Nakanishi H., Ohyanagi H., Saitoh Y., Kaibuchi K., Takai Y. (1986): J. Clin. Invest. 78, 1604.
88. Thimister P.W.L., Hopman W.P.M., Tangerman A., Rosenbusch G., Willems H.L., Jansen J.B.M.J. (1998): Hepatology 28, 1454.
89. Gomez G., Townsend C.M., Green D.W., Rajaraman S., Uchida T., Greeley G.H., Soloway R.D., Thompson J.C. (1990): J. Clin. Invest 86, 323.
90. Go V.L.W., Brooks P.P., Di Magno E.P., Gardner J.D., Lebenthal E., Scheele G.A. (eds) (1986): The Exocrine Pancreas: Biology, Pathobiology and Diseases. Raven Press, New York.
91. Holtmann G., Kelly D.G., Stemby B., Di Magno E.P. (1997): Am. J. Physiol. - Gastrointest. Liver Physiol. 273, 553.
92. Vuoristo M., Vaananen H., Miettinen T.A. (1992): Gastroenterology 102, 647.
93. Wickham M., Garrood M., Leney J., Wilson P.D.G., Fillery-Travis A. (1998): J. Lipld Res. 39, 623.
94. Amigo L., Mardones P., Ferrada C., Zanlungo S., Nervi F., Miquel J.F., Rigotti A. (2003): Hepatology 38, 727.
95. Hardcastle J., Hardcastle P., Chapman J., Taylor C. (2001): J. Pharm. Pharmacol. 53, 1457.
96. Reddy B.S.(1992): Lipids 27, 807.
97. Ochsenkuhn T., Bayerdorffer E., Meining A., Schinkel M., Thiede C., Nussler V., Sackmann M., Hatz R., Neubauer A., Paumgartner G. (1999): Cancer 85, 1665.
98. Milovic V., Teller I.C., Faust D., Caspary W.F., Stein J. (2002): Eur. J. Clin. Invest. 32, 29.
99. Blobe G.C., Obeid L.M., Hannun Y.A. (1994): Cancer Metastasis Rev. 13, 411.
100. Rao Y.P., Stravitz R.T. Vlahcevic Z.R., Gurley B.C., Sando J.J., Hylemon P.B. (1997): J. Lipid Res. 38, 2446.
101. Im E.O., Choi Y.H., Paik K.J., Suh H., Jin Y., Kim K.W., Yoo Y.H., Kim N.D. (2001): Cancer Lett. 163, 83.
102. Earnest D.L., Holubec H., Wali R.K., Jolley C.S., Bissonette M., Bhattacharyya A.K., Roy H., Khare S., Brasitus T.A. (1994): Cancer Res. 54, 5071.
103. Suh H., Jung E.J., Kim T.H., Lee H.Y., Park Y.H., Kim K.W. (1997): Cancer Lett., 113, 117.
104. Choi Y.H., Im E.O., Suh H., Jin Y., Yoo Y.H., Kim N.D. (2003): Cancer Lett. 199, 157.
105. Kuhajda K., Kevresan S., Mikov M., Sabo A., Miljkovic D. (2000): Arch. Toxicol. Kinet. Xenobiotic Metab. 8, 304.
106. Mikov M., Kuhajda K., Kandrac J. (2003): Medicinski Pregled 56, 237.
107. De Fabiani E.I., Mitro N., Godio C., Gilardi F., Caruso D., Crestani M. (2004): Biochimie 86, 771.
108. Li A.C., Glass C.K. (2004): J. Lipid Res. 45, 2161.
109. Miljkovic D., Kuhajda D., Mikov M., Kevresan S., Sabo A. (2000): U. S. Pat. 6,060,465.